These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9700024)

  • 1. In vitro and in vivo erosion of two different hydrophilic gel matrix tablets.
    Abrahamsson B; Alpsten M; Bake B; Larsson A; Sjögren J
    Eur J Pharm Biopharm; 1998 Jul; 46(1):69-75. PubMed ID: 9700024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method for measuring gel strength of controlled release hydrogel tablets using a cone/plate rheometer.
    Roshdy MN; Schwartz JB; Schnaare RL
    Pharm Dev Technol; 2001; 6(1):107-16. PubMed ID: 11247269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status.
    Guiastrennec B; Söderlind E; Richardson S; Peric A; Bergstrand M
    Pharm Res; 2017 Apr; 34(4):847-859. PubMed ID: 28155077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
    Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma scintigraphy in the analysis of ketoprofen behaviour from matrix tablets.
    Vueba ML; Rodrigues A; Lourenço P; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Int J Pharm; 2013 May; 448(1):298-304. PubMed ID: 23541984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac.
    Rahmouni M; Chouinard F; Nekka F; Lenaerts V; Leroux JC
    Eur J Pharm Biopharm; 2001 May; 51(3):191-8. PubMed ID: 11343882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of prandial effects on hydrophilic matrix tablets.
    Abrahamsson B; Roos K; Sjögren J
    Drug Dev Ind Pharm; 1999 Jun; 25(6):765-71. PubMed ID: 10349562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
    Hamed R; Al Baraghthi T; Sunoqrot S
    Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
    Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
    J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
    Turner S; Federici C; Hite M; Fassihi R
    Drug Dev Ind Pharm; 2004 Sep; 30(8):797-807. PubMed ID: 15521326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swelling, erosion and drug release characteristics of salbutamol sulfate from hydroxypropyl methylcellulose-based matrix tablets.
    Chaibva FA; Khamanga SM; Walker RB
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1497-510. PubMed ID: 20528615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer erosion and drug release characterization of hydroxypropyl methylcellulose matrices.
    Reynolds TD; Gehrke SH; Hussain AS; Shenouda LS
    J Pharm Sci; 1998 Sep; 87(9):1115-23. PubMed ID: 9724564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK; Jones AB
    Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the critical points of experimental HPMC-NaCMC hydrophilic matrices.
    Contreras L; Melgoza LM; Villalobos R; Caraballo I
    Int J Pharm; 2010 Feb; 386(1-2):52-60. PubMed ID: 19900524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro evaluation of controlled release hydrophilic matrix tablets of ketorolac tromethamine using factorial design.
    Genç L; Jalvand E
    Drug Dev Ind Pharm; 2008 Aug; 34(8):903-10. PubMed ID: 18686094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.